Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40000314
Localisation
France
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
12/10/2023
Statut
Classification
1.5°C
Année cible
2030
Statut
Targets set
Classification
1.5°C
Année cible
2050
Overall Net-Zero Target Expanscience commits to reach net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets Expanscience commits to reduce absolute scope 1 and 2 GHG emissions 46.2% by 2030 from a 2019 base year. Expanscience commits to reduce absolute scope 3 GHG emissions from purchased goods and services, fuel and energy related activities, upstream transportation and distribution, business travel, employee commuting, downstream transportation, and end of life treatment of sold products 46.2% by 2030 from a 2019 base year. Long-Term Targets Expanscience commits to reduce absolute scope 1, 2, and 3 GHG emissions 90% by 2050 from a 2019 base year.
Statut
Targets setAnnée cible
2050
Statut
BA1.5 memberDate d'engagement
27/10/2022
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
LEI
969500C4Z0KZ5S29WM22
Source : Science Based Targets initiative | Données publiques